Ghana National Pharmaceutical Manufacturing Policy | The High Street Business (THSB)

THSB Headlines

November 3, 2026November 3, 2026
Ghana Launches National Pharmaceutical Manufacturing Policy to Reverse 70% Medicine Import Dependence
November 3, 2026November 3, 2026
GACL Posts GH₵354.6 Million Profit and Pays First Dividend to Government on Airport Charge, Passenger Growth
October 31, 2026October 31, 2026
Ghana Bauxite Company Secures US$250 Million Ecobank Mandate to Expand Awaso Mine
October 31, 2026October 31, 2026
Ghana’s Urban Population Hits 58.7% as 33.7 Million Population Reshapes Demand for Housing and Services
October 31, 2026October 31, 2026
Ghana’s 70% Local Drug Production Target Faces Financing and Skills Gaps, AGI President Warns
October 31, 2026October 31, 2026
Petrol and LPG Prices Set to Drop Slightly as Diesel Faces Minor Increase in November
October 30, 2026October 30, 2026
Ghana’s Nuclear Power Push Gains Momentum as IEA Supports Institutional Readiness Programme
October 30, 2026October 31, 2026
Joseph Bukari Nikpe Hosts Polish Delegation to Explore Investment Opportunities in Ghana’s Transport Sector
October 30, 2026October 31, 2026
Joseph Bukari Nikpe Hosts Polish Delegation to Explore Investment Opportunities in Ghana’s Transport Sector
October 29, 2026October 31, 2026
Franklin Cudjoe Credits Edmond Kombat for TOR Revival, Says NPP Would Have Sold Refinery as Scrap

Ghana Launches Pharmaceutical Manufacturing Policy to Cut 70% Import Dependence

Ghana Launches National Pharmaceutical Manufacturing Policy to Reverse 70% Medicine Import Dependence

Samuel Kwame BoaduNovember 3, 2026November 3, 202606 mins

Africa’s pharmaceutical market has grown from US$215 billion to US$750 billion, yet Ghana and other African countries continue to import…

error: Content is protected. Kindly credit The High Street Business when referencing.